Atherosclerosis (BASKET)

LE WE PMID CA

Atherosclerosis (BASKET)

4005

Atherosklerose (allg)

ABCA1

AMP activated protein kinase

Angiogenesis

Anticoagulants (Coumarins Phenprocoumon Warfarin)

Anticoagulants

Apolipoprotein AI

Apolipoprotein CIII

Apoptosis

Atherosclerosis (BASKET)

Atherosclerosis (Carotids and Basilaris)

Autoantibodies Anti AGE

Autoantibodies Anti Lipoprotein

Autophagy

Bax

Blood vessels (Imaging)

Blood vessels (MRT)

Blood vessels (Physiology)

Buflomedil

Cardiovascular risk

CD36 FAT fatty acid translocase

Ceramide

Chaperone (Pharmacological)

Cholesterol

Cilostazole

COPD

Dendritic cell (Immunology)

Dendritic cell (Plasmacytoid)

Diabetes mellitus (Beta cell decay)

Efferocytosis

Ephx2

Epoxide hydrolase

Epoxyeicosatrienoic acid EET

ERS UFR (Diseases)

ERS UFR (Pharmacology)

ERS UFR (Toxikologie)

Fatty acids (saturated)

GADD153 CHOP

Glycocalyx

GSK3

Heart (Coronary heart disease BASKET)

Heart (Coronary heart disease Main stenosis)

IGF1

Imaging (Molecular)

Inflammation resolution

iNOS

Interleukin17

Interleukin24 MDA7

Lipoprotein (HDL)

Lipoprotein (OxLDL)

Lipoprotein a

Lipoprotein associated phospholipase A2

Macrophages

MCP1 Monocyte chemotactic protein1

MCPIP

MRT (Contrast agents MRT)

NADPH oxidase

Nanomedicine

Neurodegeneration

Nitric oxide NO

Nitric oxide synthetase iNOS eNOS

Obesity (BASKET)

ORAI1 CRACM1

Osteocalcin

Redox (BASKET)

Renal artery stenosis

Rho kinase

SERCA

SIRT1

Smooth muscle

STIM1

Tauroursodeoxycholic acid ttchemchaperone

Tempol

Tetrahydrobiopterin

Thrombosis (BASKET)

TLR2

Toll like receptor

Valproic acid

Vasculitis (BASKET)

YKL40

2010 1	Critical limb ischemia. [20117502] J Vasc Surg 51(1): 230-41 (2010)
2006 2	Duplex ultrasound criteria for femorofemoral bypass revision. [16950423] J Vasc Surg 44(3): 496-502 (2006)
2002 3	Pharmacologic therapy for peripheral arterial disease and claudication. [12469066] J Vasc Surg 36(6): 1283-91 (2002)
2009 4	Endovascular management of chronic infrarenal aortic occlusion. [19281286] J Endovasc Ther 16(1): 84-92 (2009)
2007 5	Role of clopidogrel in managing atherothrombotic cardiovascular disease. [17371888] Ann Intern Med 146(6): 434-41 (2007)
2007 6	Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force. [18087057] Ann Intern Med 147(12): 860-70 (2007)
2007 7	Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. [18087056] Ann Intern Med 147(12): 854-9 (2007)
1995 8	Noninvasive carotid artery testing. A meta-analytic review. [7847648] Ann Intern Med 122(5): 360-7 (1995)
2008 9	Carotid plaque computed tomography imaging in stroke and nonstroke patients. [18756475] Ann Neurol 64(2): 149-57 (2008)
2007 10	Real-world replication of randomized controlled trial results for carotid endarterectomy. [17923633] Arch Neurol 64(10): 1496-500 (2007)
2006 11	Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist. [16401733] Arch Neurol 63(1): 20-4 (2006)
2004 12	Diffusion-weighted magnetic resonance imaging in internal carotid artery dissection. [15096398] Arch Neurol 61(4): 510-2 (2004)
2004 13	Basilar occlusive disease: the descent of the feared foe? [15096392] Arch Neurol 61(4): 471-2 (2004)
2002 14	Spontaneous intracranial internal carotid artery dissection: report of 10 patients. [12056934] Arch Neurol 59(6): 977-81 (2002)
2001 15	Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis. [11594932] Arch Neurol 58(10): 1690-2 (2001)
2001 16	Stroke with internal carotid artery stenosis. [11295991] Arch Neurol 58(4): 605-9 (2001)
2000 17	Carotid endarterectomy: a neurotherapeutic advance. [10634431] Arch Neurol 57(1): 40-5 (2000)
2008 18	Role of carotid duplex imaging in carotid screening programmes - an overview. [18601737] Cardiovasc Ultrasound 6(): 34 (2008)
2008 19	Atherosclerotic Peripheral Vascular Disease Symposium II: controversies in carotid artery revascularization. [19106407] Circulation 118(25): 2852-9 (2008)
2007 20	The argument to support broader application of extracranial carotid artery stent technology. [17909116] Circulation 116(14): 1602-10; discussion 1610 (2007)
2007 21	Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. [17242284] Circulation 115(4): 459-67 (2007)
2006 22	Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. [16636190] Circulation 113(16): 2021-30 (2006)
1995 23	Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. [7805271] Circulation 91(2): 566-79 (1995)
2008 24	Bifurcation lesions: a never-ending challenge. [19001471] Eur Heart J 29(23): 2831-2 (2008)
2008 25	Symptomatic carotid artery stenosis: the dilemma for a reasonable selection of carotid stenting or endarterectomy. [18167365] Eur Heart J 29(1): 7-9 (2008)
2008 26	Safety of carotid artery stenting for symptomatic carotid artery disease: a meta-analysis. [17881346] Eur Heart J 29(1): 113-9 (2008)
2003 27	Carotid artery stenting. [12860884] Heart 89(8): 944-8 (2003)
2005 28	Cerebral revascularisation: where are we now? [15774426] J Neurol Neurosurg Psychiatry 76(4): 463-5 (2005)
1999 29	Detecting carotid stenoses. [9886442] J Neurol Neurosurg Psychiatry 66(1): 4 (1999)
1995 30	Imaging blood vessels of the head and neck. [7673947] J Neurol Neurosurg Psychiatry 59(3): 225-37 (1995)
1993 31	Cranial nerve palsies in spontaneous carotid artery dissection. [8229030] J Neurol Neurosurg Psychiatry 56(11): 1191-9 (1993)
2009 32	Treatment of carotid artery stenosis: medical therapy, surgery, or stenting? [19339655] Mayo Clin Proc 84(4): 362-87; quiz 367-8 (2009)
2007 33	Diagnosis and invasive management of carotid atherosclerotic stenosis. [17605967] Mayo Clin Proc 82(7): 851-8 (2007)
2007 34	Antiplatelet therapy for atherothrombotic disease: an update for the primary care physician. [17511957] Mayo Clin Proc 82(5): 583-93 (2007)
2006 35	Platelets in atherothrombosis. [16438480] Mayo Clin Proc 81(1): 59-68 (2006)
2004 36	Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting. [15357045] Mayo Clin Proc 79(9): 1197-208 (2004)
2004 37	Evaluation and management of asymptomatic carotid artery stenosis. [15244395] Mayo Clin Proc 79(7): 937-44 (2004)
2005 38	Carotid and vertebral artery dissection syndromes. [15937204] Postgrad Med J 81(956): 383-8 (2005)
1998 39	Angioplasty and stenting in the carotid and vertebral arteries. [9538479] Postgrad Med J 74(867): 7-10 (1998)
2008 40	The role of carotid artery stenting and carotid endarterectomy in cognitive performance: a systematic review. [18723423] Stroke 39(11): 3116-27 (2008)
2008 41	Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: a systematic review and meta-analysis. [18556586] Stroke 39(8): 2237-48 (2008)
2008 42	New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature. [18388346] Stroke 39(6): 1911-9 (2008)
2007 43	Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease. [17585085] Stroke 38(8): 2391-6 (2007)
2007 44	Stenting for middle cerebral artery stenosis: inevitable but when and how. [17332460] Stroke 38(4): 1422 (2007)
2007 45	Carotid stenting for asymptomatic carotid stenosis: trial it. [17261723] Stroke 38(2 Suppl): 715-20 (2007)
2007 46	Endarterectomy and stenting for asymptomatic carotid stenosis: a race at breakneck speed. [17261722] Stroke 38(2 Suppl): 707-14 (2007)
2007 47	Intra-arterial thrombolysis for basilar artery thrombosis: trial it. [17261721] Stroke 38(2 Suppl): 704-6 (2007)
2007 48	Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. [17261720] Stroke 38(2 Suppl): 701-3 (2007)
2007 49	Intracranial hemorrhage associated with revascularization therapies. [17234988] Stroke 38(2): 431-40 (2007)
2006 50	Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. [16960090] Stroke 37(10): 2562-6 (2006)
2005 51	The vulnerable carotid artery plaque: current imaging methods and new perspectives. [16282537] Stroke 36(12): 2764-72 (2005)
2005 52	Low-grade carotid stenosis: looking beyond the lumen with MRI. [16239630] Stroke 36(11): 2504-13 (2005)
2005 53	Endovascular revascularization of symptomatic acute extracranial internal carotid artery occlusion. [16239628] Stroke 36(11): 2335-6 (2005)
2005 54	Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. [16179564] Stroke 36(10): 2072-6 (2005)
2005 55	Improved perioperative outcomes from carotid endarterectomy: yet another statin side effect? [16179560] Stroke 36(10): 2058-9 (2005)
2005 56	A systematic review of the risk factors for cervical artery dissection. [15933263] Stroke 36(7): 1575-80 (2005)
2005 57	A critical appraisal of the performance, reporting, and interpretation of studies comparing carotid plaque imaging with histology. [15774817] Stroke 36(5): 1091-7 (2005)
2005 58	Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. [15746454] Stroke 36(4): 905-11 (2005)
2005 59	Systematic review of early recurrent stenosis after carotid angioplasty and stenting. [15625299] Stroke 36(2): 367-73 (2005)
2004 60	Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. [15514180] Stroke 35(12): 2902-9 (2004)
2004 61	Systematic review of computed tomographic angiography for assessment of carotid artery disease. [15345798] Stroke 35(10): 2306-12 (2004)
2004 62	Reporting standards for carotid artery angioplasty and stent placement. [15105523] Stroke 35(5): e112-34 (2004)
2004 63	Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy. [15060325] Stroke 35(5): 1227-8 (2004)
2004 64	Antithrombotic drugs for carotid artery dissection. [14739417] Stroke 35(2): 613-4 (2004)
2003 65	Extracranial carotid artery stenosis. [14563961] Stroke 34(11): 2767-73 (2003)
2003 66	Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. [12920260] Stroke 34(9): 2290-301 (2003)
2003 67	Revisiting the appropriateness of carotid endarterectomy. [12738896] Stroke 34(6): 1464-71 (2003)
2003 68	Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. [12690221] Stroke 34(5): 1324-32 (2003)
2000 69	The symptomatic carotid plaque. [10700518] Stroke 31(3): 774-81 (2000)
1999 70	Circle of Willis collateral flow investigated by magnetic resonance angiography. [10582995] Stroke 30(12): 2671-8 (1999)
1999 71	Carotid endarterectomy : where do we draw the line? [10471418] Stroke 30(9): 1745-50 (1999)
1998 72	Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. [9660392] Stroke 29(7): 1389-92 (1998)
1997 73	Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. [9341723] Stroke 28(10): 2084-93 (1997)
1996 74	A systematic comparison of the risks of stroke and death due to carotid endarterectomy for symptomatic and asymptomatic stenosis. [8571421] Stroke 27(2): 266-9 (1996)
1996 75	A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. [8571420] Stroke 27(2): 260-5 (1996)
1995 76	Skepticism toward carotid ultrasonography. A virtue, an attitude, or fanaticism? [7570718] Stroke 26(10): 1743-6 (1995)
1995 77	Detection of carotid stenosis. From NASCET results to clinical practice. [7631330] Stroke 26(8): 1325-8 (1995)
1995 78	Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. [7839390] Stroke 26(1): 188-201 (1995)
1988 79	Reversible cerebral segmental vasoconstriction. [3046073] Stroke 19(9): 1159-70 (1988)
1987 80	Extracranial vertebral artery dissections: a review of 13 cases. [3318002] Stroke 18(6): 1037-47 (1987)
1984 81	Pathophysiology of extracranial cerebral arterial stenosis--a critical review. [6367152] Stroke 15(2): 224-36 (1984)
1982 82	Cervical arteriosclerosis--diagnostic advances in need of a clinical answer. [6750861] Stroke 13(5): 551-6 (1982)
1982 83	The natural history of asymptomatic carotid bifurcation plaques. [7101345] Stroke 13(4): 459-64 (1982)
1982 84	Asymptomatic carotid artery disease. [7101341] Stroke 13(4): 431-3 (1982)
2000 85	New developments in endovascular interventions for extracranial carotid stenosis. [11093412] Tex Heart Inst J 27(3): 273-80 (2000)
1988 86	Carotid endarterectomy: from first recorded case to present. [15227240] Tex Heart Inst J 15(3): 139-41 (1988)
1993 87	Carotid endarterectomy--the big picture. [8351920] West J Med 159(1): 90-1 (1993)
1993 88	Carotid endarterectomy for prevention of stroke. [8351903] West J Med 159(1): 37-43 (1993)
1991 89	[Analysis of Doppler sonographic findings in diabetic pregnancies]. [1790915] Gynakol Rundsch 31 Suppl 2(-): 169-73 (1991)
2007 90	ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). [17207736] J Am Coll Cardiol 49(1): 126-70 (2007)
2004 91	Molecular regulation of vascular smooth muscle cell differentiation in development and disease. [15269336] Physiol Rev 84(3): 767-801 (2004)
2004 92	Molecular, endocrine, and genetic mechanisms of arterial calcification. [15294885] Endocr Rev 25(4): 629-72 (2004)
2008 93	Nanoscale architecture in atherosclerotic calcification. [18946051] Arterioscler Thromb Vasc Biol 28(11): 1882-4 (2008)
2006 94	Molecular mechanisms of vascular calcification: lessons learned from the aorta. [16601233] Arterioscler Thromb Vasc Biol 26(7): 1423-30 (2006)
2005 95	Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype. [15790939] Arterioscler Thromb Vasc Biol 25(4): 651-4 (2005)
2004 96	Vascular calcification: mechanisms and clinical ramifications. [15155384] Arterioscler Thromb Vasc Biol 24(7): 1161-70 (2004)
2006 97	Vascular calcification: pathobiological mechanisms and clinical implications. [17095733] Circ Res 99(10): 1044-59 (2006)
2005 98	Bone morphogenetic proteins in vascular calcification. [16037577] Circ Res 97(2): 105-14 (2005)
2005 99	Angiogenesis and pericytes in the initiation of ectopic calcification. [15890980] Circ Res 96(9): 930-8 (2005)
2005 100	Regulation of vascular calcification: roles of phosphate and osteopontin. [15831823] Circ Res 96(7): 717-22 (2005)
2004 101	Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. [15564564] Circ Res 95(11): 1046-57 (2004)
2004 102	Pathophysiology of vascular calcification in chronic kidney disease. [15375022] Circ Res 95(6): 560-7 (2004)
2008 103	Vascular calcification: pathobiology of a multifaceted disease. [18519861] Circulation 117(22): 2938-48 (2008)
2006 104	Vitamin K epoxide reductase complex and vascular calcification: is this the important link between vitamin K and the arterial vessel wall? [16567578] Circulation 113(12): 1550-2 (2006)
2008 105	Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. [18667741] Clin J Am Soc Nephrol 3(6): 1585-98 (2008)
2008 106	Vitamin K-dependent proteins, warfarin, and vascular calcification. [18495950] Clin J Am Soc Nephrol 3(5): 1504-10 (2008)
2008 107	Mechanisms of vascular calcification in chronic kidney disease. [18094365] J Am Soc Nephrol 19(2): 213-6 (2008)
2006 108	Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. [17130273] J Am Soc Nephrol 17(12 Suppl 3): S267-73 (2006)
2004 109	Vascular calcification mechanisms. [15579497] J Am Soc Nephrol 15(12): 2959-64 (2004)
2009 110	The emerging role of phosphate in vascular calcification. [19145240] Kidney Int 75(9): 890-7 (2009)
2001 111	Pathophysiological mechanisms of vascular calcification in end-stage renal disease. [11473629] Kidney Int 60(2): 472-9 (2001)
2009 112	Vascular and other tissue calcification in peritoneal dialysis patients. [19270239] Perit Dial Int 29 Suppl 2(): S9-S14 (2009)
2007 113	An overview of the pathophysiology of vascular calcification in chronic kidney disease. [17556308] Perit Dial Int 27 Suppl 2(): S215-22 (2007)
2003 114	Imaging of the vulnerable plaque: new modalities. [14632365] South Med J 96(11): 1142-7 (2003)
2008 115	Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis. [18375475] QJM 101(7): 519-27 (2008)
2007 116	Atherosclerosis imaging in statin intervention trials. [17456609] QJM 100(5): 253-62 (2007)
2008 117	From vulnerable plaque to atherothrombosis. [18410594] J Intern Med 263(5): 506-16 (2008)
2004 118	Pathologic assessment of the vulnerable human coronary plaque. [15547008] Heart 90(12): 1385-91 (2004)
2003 119	Basic aspects of plaque vulnerability. [12975444] Heart 89(10): 1262-7 (2003)
2000 120	Glagovian remodelling, plaque composition, and stenosis generation. [11039994] Heart 84(5): 461-2 (2000)
1990 121	Atherosclerosis and molecular pathology: mechanisms of cholesteryl ester accumulation in foam cells and extracellular space of atherosclerotic lesions. [2290125] J Pharmacobiodyn 13(7): 385-413 (1990)
2008 122	Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. [18218686] Cardiovasc Res 78(1): 8-17 (2008)
1999 123	Mechanisms of plaque rupture: mechanical and biologic interactions. [10341836] Cardiovasc Res 41(2): 369-75 (1999)
1999 124	Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. [10341835] Cardiovasc Res 41(2): 361-8 (1999)
1999 125	Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. [10341834] Cardiovasc Res 41(2): 345-60 (1999)
1999 126	Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability. [10341833] Cardiovasc Res 41(2): 334-44 (1999)
1999 127	Pathophysiology and clinical significance of atherosclerotic plaque rupture. [10341832] Cardiovasc Res 41(2): 323-33 (1999)
1999 128	Plaque instability--the real challenge for atherosclerosis research in the next decade? [10341831] Cardiovasc Res 41(2): 321-2 (1999)
2005 129	Inhibition and regression of atherosclerotic lesions. [15940346] Acta Biochim Pol 52(2): 311-9 (2005)
2010 130	Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis. [20526859] Angiogenesis 13(2): 87-99 (2010)
2010 131	Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions. [20411320] Angiogenesis 13(2): 189-202 (2010)
2008 132	Media calcification and intima calcification are distinct entities in chronic kidney disease. [18815240] Clin J Am Soc Nephrol 3(6): 1599-605 (2008)
2005 133	Novel determinants of plaque instability. [16102103] J Thromb Haemost 3(9): 1962-75 (2005)
2005 134	Vessel wall apoptosis and atherosclerotic plaque instability. [15748235] J Thromb Haemost 3(3): 465-72 (2005)
2004 135	The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. [15613016] J Thromb Haemost 2(12): 2118-32 (2004)
2004 136	Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. [15215157] Am J Pathol 165(1): 1-10 (2004)
1998 137	Risk factors and progression of atherosclerosis in youth. PDAY Research Group. Pathological Determinants of Atherosclerosis in Youth. [9777934] Am J Pathol 153(4): 1023-33 (1998)
1977 138	Structural changes within the media of coronary arteries related to intimal thickening. [333934] Am J Pathol 89(1): 13-34 (1977)
1980 139	Atherosclerosis. Regression in nonhuman primates. [6766822] Circ Res 46(3): 311-20 (1980)
1995 140	A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. [7648691] Circulation 92(5): 1355-74 (1995)
1995 141	Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. [7729036] Circulation 91(9): 2488-96 (1995)
2006 142	Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art. [16705212] J Lipid Res 47(8): 1677-99 (2006)
2004 143	Thematic review series: The pathogenesis of atherosclerosis. Toward a biological network for atherosclerosis. [15292376] J Lipid Res 45(10): 1793-805 (2004)
2002 144	Atherogenesis--recent insights into basic mechanisms and their clinical impact. [12454211] Nephrol Dial Transplant 17(12): 2055-64 (2002)
2008 145	Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences. [18772323] J Appl Physiol 105(5): 1643-51 (2008)
2010 146	Experimental atherosclerosis in rabbits. [20857052] Arq Bras Cardiol 95(2): 272-8 (2010)
2008 147	Risk factors for the development of atherosclerosis in childhood and adolescence. [18516390] Arq Bras Cardiol 90(4): 276-283 (2008)
2009 148	Mechanisms and consequences of efferocytosis in advanced atherosclerosis. [19414539] J Leukoc Biol 86(5): 1089-95 (2009)
2009 149	Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis. [19309350] Clin Exp Immunol 156(3): 377-85 (2009)
2010 150	The expression and functions of toll-like receptors in atherosclerosis. [20652007] Mediators Inflamm 2010(-): 393946 (2010)
2010 151	Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. [20652043] Mediators Inflamm 2010(-): 174341 (2010)
2008 152	Atherosclerosis as a disease of failed endogenous repair. [18508460] Front Biosci 13(-): 3621-36 (2008)
2010 153	ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. [20485864] Mol Med 16(9-10): 438-49 (2010)
2011 154	Application of MRI to detect high-risk atherosclerotic plaque. [21615314] Expert Rev Cardiovasc Ther 9(5): 545-50 (2011)
2008 155	Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process. [18319293] QJM 101(7): 513-8 (2008)
2003 156	Tumor suppressor MDA-7/IL-24 selectively inhibits vascular smooth muscle cell growth and migration. [12907144] Mol Ther 8(2): 220-9 (2003)
2009 157	Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis. [19095952] Am J Pathol 174(1): 330-42 (2009)
2010 158	Prelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivo. [19897713] Am J Physiol Heart Circ Physiol 298(1): H163-70 (2010)
2009 159	Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. [19243235] Antioxid Redox Signal 11(9): 2333-9 (2009)
2010 160	The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. [20651282] Arterioscler Thromb Vasc Biol 30(10): 1925-32 (2010)
2006 161	Nitric oxide and endoplasmic reticulum stress. [16645155] Arterioscler Thromb Vasc Biol 26(7): 1439-46 (2006)
2012 162	Macrophage autophagy plays a protective role in advanced atherosclerosis. [22445600] Cell Metab 15(4): 545-53 (2012)
2010 163	Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. [21035758] Cell Metab 12(5): 467-82 (2010)
2010 164	Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. [20124121] Circulation 121(6): 792-803 (2010)
2007 165	Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. [17709641] Circulation 116(11): 1226-33 (2007)
2009 166	Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. [19566488] Clin Sci (Lond) 117(3): 95-109 (2009)
2011 167	Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia. [21568932] Curr Mol Med 11(5): 391-400 (2011)
2008 168	Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. [18211830] Free Radic Biol Med 44(7): 1232-45 (2008)
2009 169	Tetrahydrobiopterin, superoxide, and vascular dysfunction. [19628033] Free Radic Biol Med 47(8): 1108-19 (2009)
2010 170	IGF-1, oxidative stress and atheroprotection. [20071192] Trends Endocrinol Metab 21(4): 245-54 (2010)
2008 171	Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. [18488431] Int J Chron Obstruct Pulmon Dis 3(1): 89-96 (2008)
2011 172	Jeremiah Metzger Lecture: cholesterol, inflammation and atherosclerotic cardiovascular disease: is it all LDL? [21686232] Trans Am Clin Climatol Assoc 122(-): 256-89 (2011)
2010 173	Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. [20697562] Trans Am Clin Climatol Assoc 121(-): 206-20 (2010)
2010 174	HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. [20687877] Curr Pharm Des 16(28): 3173-84 (2010)
2009 175	Rho kinase: an important mediator of atherosclerosis and vascular disease. [19754385] Curr Pharm Des 15(27): 3108-15 (2009)
2010 176	SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. [20215708] J Atheroscler Thromb 17(5): 431-5 (2010)
2010 177	Adipose tissue, inflammation and atherosclerosis. [20124732] J Atheroscler Thromb 17(4): 332-41 (2010)
2010 178	An update on the role of markers of inflammation in atherosclerosis. [20032572] J Atheroscler Thromb 17(1): 1-11 (2010)
2009 179	Apolipoprotein CIII links dyslipidemia with atherosclerosis. [19262004] J Atheroscler Thromb 16(1): 6-11 (2009)
2008 180	Antiatherogenic functionality of high density lipoprotein: how much versus how good. [18385533] J Atheroscler Thromb 15(2): 52-62 (2008)
2009 181	The high-risk thin-cap fibroatheroma: a new kid on the block. [20031766] Circ Cardiovasc Interv 2(6): 500-2 (2009)
2008 182	Intimal hyperplasia in murine models. [18336244] Curr Drug Targets 9(3): 251-60 (2008)
2008 183	Progression and disruption of advanced atherosclerotic plaques in murine models. [18336239] Curr Drug Targets 9(3): 210-6 (2008)
2011 184	The autoimmune concept of atherosclerosis. [21881502] Curr Opin Lipidol 22(5): 327-34 (2011)
2008 185	Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis. [18769227] Curr Opin Lipidol 19(5): 462-8 (2008)
2009 186	Macrophage heterogeneity in atherosclerotic plaques. [19741337] Curr Opin Lipidol 20(5): 370-8 (2009)
2009 187	Atherosclerosis imaging: prognostically useful or merely more of what we know? [19808581] Circ Cardiovasc Imaging 2(2): 150-60 (2009)
2010 188	Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis. [20730693] Curr Opin Investig Drugs 11(9): 989-96 (2010)
2009 189	Inflammation in atherosclerosis: from pathophysiology to practice. [19942084] J Am Coll Cardiol 54(23): 2129-38 (2009)
2010 190	Soluble epoxide hydrolase in atherosclerosis. [20425256] Curr Atheroscler Rep 12(3): 174-83 (2010)
2010 191	Insights into atherosclerosis using nanotechnology. [20425261] Curr Atheroscler Rep 12(3): 209-15 (2010)
2010 192	Recent developments with lipoprotein-associated phospholipase A2 inhibitors. [20425270] Curr Atheroscler Rep 12(1): 43-7 (2010)
2007 193	Cilostazol in the management of vascular disease. [17353881] Int Angiol 26(1): 1-7 (2007)
2009 194	Buflomedil: potential new indications for an old agent. [19174750] Int Angiol 28(3): 170-4 (2009)
2010 195	Monocytes in atherosclerosis: subsets and functions. [20065951] Nat Rev Cardiol 7(2): 77-86 (2010)
2010 196	Macrophage cholesteryl ester mobilization and atherosclerosis. [19878739] Vascul Pharmacol 52(1-2): 1-10 (2010)
2010 197	An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide. [19883911] Atherosclerosis 209(1): 18-27 (2010)
2008 198	Ceramide: a common pathway for atherosclerosis? [17963772] Atherosclerosis 196(2): 497-504 (2008)
2009 199	YKL-40--an emerging biomarker in cardiovascular disease and diabetes. [19930630] Cardiovasc Diabetol 8(-): 61 (2009)
2010 200	Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. [20299739] J Med Invest 57(1-2): 12-25 (2010)
2011 201	TGF-β and restenosis revisited: a Smad link. [21324395] J Surg Res 167(2): 287-97 (2011)
2010 202	Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. [19851078] J Vasc Res 47(2): 168-80 (2010)
2010 203	Immunomodulation of vascular diseases: atherosclerosis and autoimmunity. [20188603] Eur J Vasc Endovasc Surg 39(4): 485-94 (2010)
2009 204	Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. [19946412] J Angiogenes Res 1(-): 4 (2009)
2009 205	Novel markers of peripheral arterial disease. [19808725] Vasc Med 14(4): 381-92 (2009)
2007 206	Pathology of atherosclerosis and stenting. [17826632] Neuroimaging Clin N Am 17(3): 285-301, vii (2007)
2011 207	The role of peroxidases in the pathogenesis of atherosclerosis. [21871172] BMB Rep 44(8): 497-505 (2011)
2009 208	Innate and adaptive immunity in atherosclerosis. [19449008] Semin Immunopathol 31(1): 5-22 (2009)
2010 209	Clinical significance of the humoral immune response to modified LDL. [19427818] Clin Immunol 134(1): 55-65 (2010)
2010 210	Dendritic cells in atherosclerotic disease. [19520615] Clin Immunol 134(1): 25-32 (2010)
2010 211	Innate immunity in atherosclerosis. [20505313] J Innate Immun 2(4): 305-6 (2010)
2010 212	Emerging role of IL-17 in atherosclerosis. [20505315] J Innate Immun 2(4): 325-33 (2010)
2010 213	Dendritic cells and their role in atherogenesis. [20458277] Lab Invest 90(7): 970-84 (2010)
2005 214	The role of shear stress in the pathogenesis of atherosclerosis. [15568038] Lab Invest 85(1): 9-23 (2005)
2010 215	Gene activation regresses atherosclerosis, promotes health, and enhances longevity. [20604930] Lipids Health Dis 9(-): 67 (2010)
2010 216	STIM and Orai proteins: players in sexual differences in hypertension-associated vascular dysfunction? [20001956] Clin Sci (Lond) 118(6): 391-6 (2010)
2005 217	Pathway analysis of coronary atherosclerosis. [15942018] Physiol Genomics 23(1): 103-18 (2005)
2007 218	Genetic and genomic insights into the molecular basis of atherosclerosis. [17767904] Cell Metab 6(3): 164-79 (2007)
PMC 219	Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b. [23948654] Circ Res 113(9):1054-64 (2013)
PMC 220	A major role for RCAN1 in atherosclerosis progression. [24127415] EMBO Mol Med 5(12):1901-17 (2013)
PMC 221	Dendritic cells and regulatory T cells in atherosclerosis. [22752759] Mol Cells 34(4):341-7 (2012)
PMC 222	Local proliferation dominates lesional macrophage accumulation in atherosclerosis. [23933982] Nat Med 19(9):1166-72 (2013)
PMC 223	Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators. [23153419] Trends Endocrinol Metab 24(3):137-44 (2013)
PMC 224	Protective Role for Properdin in Progression of Experimental Murine Atherosclerosis. [24667818] PLoS One 9(3): (2014)
PMC 225	Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice. [24701228] Arch Med Sci 10(1):154-60 (2014)
PMC 226	AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction. [23413429] Arterioscler Thromb Vasc Biol 33(4):795-804 (2013)
PMC 227	Advances in molecular imaging of atherosclerotic vascular disease. [18830079] Curr Opin Cardiol 23(6):620-8 (2008)
PMC 228	Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials. [24711989] Front Cell Infect Microbiol 4():34 (2014)
PMC 229	Cooling the fire of atherosclerosis with heat shock protein 27. [23747762] J Am Coll Cardiol 62(16):1455-6 (2013)
PMC 230	Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity. [23378601] J Lipid Res 54(4):1124-34 (2013)
PMC 231	Bone marrow stem cell injection for the treatment of critical limb ischemia. [24693015] J Stem Cells Regen Med 3(1):15-8 (2007)
PMC 232	Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases. [24757525] Ther Adv Vaccines 2(2):56-66 (2014)
PMC 233	Hypoxia in murine atherosclerotic plaques and its adverse effects on macrophages. [23375596] Trends Cardiovasc Med 23(3):80-4 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Atherosclerosis (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Atherosclerosis (BASKET).php on line 92